Genzyme corp, Genzyme Corporation • For the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on hemodialysis.
Sevelamer is a phosphate binder used to treat hyperphosphatemia.
Sevelamer prevents hyperphosphatemia by binding to dietary phosphate in the gut, preventing its absorption and thus decreasing serum parathyroid hormone levels.